Amedisys, Inc.

Total Valuation

Amedisys, Inc. carries a market capitalization of 3.32B, placing it among publicly traded companies globally. Its enterprise value stands at 3.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Amedisys, Inc. currently has 32.88M shares outstanding.

Valuation Ratios

Amedisys, Inc. trades at a trailing price-to-earnings ratio of 37.67. The price-to-sales ratio is 1.34, and the price-to-book ratio stands at 3.66.

Enterprise Valuation

On an enterprise value basis, Amedisys, Inc. trades at an EV/EBITDA multiple of 11.75 and an EV/FCF ratio of 13.01. The EV/Sales ratio of 1.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.96 provides insight into valuation relative to core operating earnings.

Financial Position

Amedisys, Inc. maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.34, indicating elevated leverage, while an interest coverage ratio of 10.43 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Amedisys, Inc. posts a return on equity of 10.22 and a return on invested capital of 7.34.

Taxes

Over the trailing twelve months, Amedisys, Inc. has paid 67.42M in income taxes, reflecting an effective tax rate of 45.16.

Stock Price Statistics

Amedisys, Inc.'s stock has gained approximately 4.21009% over the past 52 weeks. The 50-day moving average sits at 97.76, while the 200-day moving average is 93.41.

Income Statement

Over the trailing twelve months, Amedisys, Inc. generated 2.40B in revenue and converted that into 85.63M in net income, yielding earnings per share of 2.47. EBITDA reached 287.78M, while operating income came in at 226.03M.

Balance Sheet

Amedisys, Inc. holds 337.30M in cash and equivalents against 450.51M in total debt, resulting in a net debt position of 25.92M. Total book value stands at 880.29M, with working capital of 173.84M providing operational flexibility.

Cash Flow

Amedisys, Inc. produced 239.43M in operating cash flow over the past twelve months. After subtracting -5.25M in capital expenditures, free cash flow totaled 234.18M - equivalent to 7.14 per share.

Margins

Amedisys, Inc. operates with a gross margin of 43.19, reflecting its pricing power and cost economics. The operating margin of 9.41 and net profit margin of 3.56 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Amedisys, Inc.'s most recent stock split took place on December 5, 2006 with a 3:4 split ratio.

Scores

Amedisys, Inc. posts an Altman Z-Score of 7.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.